News

US Gestational Diabetes Prevalence May Be as High as 9.4%

Author and Disclosure Information

 

References

The rate of gestational diabetes in the United States is somewhere between 4.6% and 9.4%, according to investigators from the Centers for Disease Control and Prevention.

Researchers compared data from birth certificates collected from 16 states to data from the Pregnancy Risk Assessment Monitoring System (PRAMS) in 21 states. PRAMS is a CDC-led surveillance project that works with state health departments to collect population-based data on maternal experiences before, during, and after pregnancy.

In 2010, the prevalence of gestational diabetes mellitus was 4.6% as listed on birth certificates, 8.7% on the PRAMS scale, and 9.2% as reported on either the PRAMS scale or birth certificates. The percent agreement between the sources was 94.1%, wrote Carla L. DeSisto, M.P.H., and her associates at the CDC (Prev. Chronic Dis. 2014;11:130415[doi:10.5888/pcd11.130415]).

There was no significant difference in gestational diabetes prevalence between the two study periods examined – 8.1% in 2007-08 and 8.5% in 2009-10, according to an analysis of PRAMS data from 123,373 women. In both time periods, Utah had the lowest prevalence (5.7% and 5.6%, respectively) and Rhode Island had the highest (10.4% and 11.7%).

Recommended Reading

Cancer Risk Elevated Before and 90 Days After Diabetes Diagnosis
Type 2 Diabetes ICYMI
Is your patient on target? Optimizing diabetes management
Type 2 Diabetes ICYMI
Diabetes care: Whose goals are they?
Type 2 Diabetes ICYMI
Calcium and Vitamin D Improve Metabolic Profile in Gestational Diabetes
Type 2 Diabetes ICYMI
TTP399 for type 2 diabetes shows promise
Type 2 Diabetes ICYMI
Reassuring results on cardiovascular safety of DPP-4 inhibitors
Type 2 Diabetes ICYMI
‘Walkable’ neighborhoods may be protective against diabetes
Type 2 Diabetes ICYMI
FDA approves empagliflozin for adults with type 2 diabetes
Type 2 Diabetes ICYMI
AADE14 Coverage Begins Aug. 7
Type 2 Diabetes ICYMI
Is Your Patient on Target? Optimizing Diabetes Management
Type 2 Diabetes ICYMI